Our Cases

Compass Lexecon has been involved in many of the largest and most complex antitrust litigation and financial market cases over the past 30 years.

Find a Case

Sorry, your search didn't return any results.

08/19/19

In December 2018, GlaxoSmithKline plc (GSK) and Pfizer Inc. agreed to combine their consumer healthcare businesses through a multi-billion dollar transaction. GSK markets common over the counter health care products such as Excedrin, TUMs, Prevacid, and Triaminic, while Pfizer markets...

07/11/19

On 27 June 2019, the European Commission unconditionally approved the acquisition of Red Hat by IBM at Phase I. The Commission’s clearance decision followed unconditional approvals by the U.S. Department of Justice and several other national competition authorities. The $34...

03/16/18

On March 16, 2018, Suzano Papel e Celulose S.A. (“Suzano”) announced its plan to acquire Fibria Celulose S.A. (“Fibria”). The two companies are both leading Brazilian suppliers of eucalyptus pulp in the Americas, Europe, and Asia. Compass Lexecon was retained...

07/17/15

In June 2015, the Competition Appeal Court of South Africa (the CAC) absolved Sasol Chemical Industries of the excessive pricing complaint against it. In doing so, the CAC overturned the decision of the Competition Tribunal. Compass Lexecon initially advised Sasol...

05/05/11

On May 5, 2011, the European Commission (EC) cleared without conditions the proposed combination of Citrovita (Votorantim group) and Citrosuco (Fisher group) to form the world’s largest wholesale supplier of orange juice. Unconditional clearance was awarded after an in-depth, Phase...